Evidence map›Paper›PMID 24114306›Full record

Trial reportBMJ (Clinical research ed.)2013

Clinical score and rapid antigen detection test to guide antibiotic use for sore throats: randomised controlled trial of PRISM (primary care streptococcal management).

Paul Little, F D Richard Hobbs, Michael Moore, David Mant, Ian Williamson, Cliodna McNulty, Ying Edith Cheng, Geraldine Leydon, Richard McManus, Joanne Kelly and 4 more

Erratum issuedOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ (Clinical research ed.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 82 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 6 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 6 syntheses or guidelines pooled it, 157 citations in OpenAlex.

  1. Pooled it
  2. Predictors of rheumatic fever in sore throat patients: a systematic review and meta-analysis.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2022
    Pooled it
  3. Clinical Practice Guideline: Sore Throat.Deutsches Arzteblatt international · 2021
    Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Antibiotic effectiveness for children with lower respiratory infections: prospective cohort and trial in primary care.The British journal of general practice : the journal of the Royal College of General Practitioners · 2023
    Trial
  9. Trial
  10. Prevalence of Group AThe American journal of tropical medicine and hygiene · 2020
    Trial
  11. Trial
  12. Trial
  13. Trial
  14. Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis of potential high-risk groups.The British journal of general practice : the journal of the Royal College of General Practitioners · 2014
    Trial
  15. Review
  16. Article
  17. Article
  18. Article
  19. The burden of group AiScience · 2025
    Review
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Paul LittleUniversity of Southampton Medical School, Aldermoore Health Centre, Southampton SO16 5ST, UK.
F D Richard Hobbs
Michael Moore
David Mant
Ian Williamson
Cliodna McNulty
Ying Edith Cheng
Geraldine Leydon
Richard McManus
Joanne Kelly
Jane Barnett
Paul Glasziou
Mark Mullee
PRISM investigators
University of Southampton · GBUniversity of Birmingham · GBBond University · AUGloucestershire Royal Hospital · GBUniversity of Oxford · GB

Funding

Department of Health 05/10/01
6 · The paper itself

Abstract

objectiveTo determine the effect of clinical scores that predict streptococcal infection or rapid streptococcal antigen detection tests compared with delayed antibiotic prescribing.

designOpen adaptive pragmatic parallel group randomised controlled trial.

settingPrimary care in United Kingdom. PATIENTS: Patients aged ≥ 3 with acute sore throat.

interventionAn internet programme randomised patients to targeted antibiotic use according to: delayed antibiotics (the comparator group for analyses), clinical score, or antigen test used according to clinical score. During the trial a preliminary streptococcal score (score 1, n=1129) was replaced by a more consistent score (score 2, n=631; features: fever during previous 24 hours; purulence; attends rapidly (within three days after onset of symptoms); inflamed tonsils; no cough/coryza (acronym FeverPAIN). OUTCOMES: Symptom severity reported by patients on a 7 point Likert scale (mean severity of sore throat/difficulty swallowing for days two to four after the consultation (primary outcome)), duration of symptoms, use of antibiotics.

resultsFor score 1 there were no significant differences between groups. For score 2, symptom severity was documented in 80% (168/207 (81%) in delayed antibiotics group; 168/211 (80%) in clinical score group; 166/213 (78%) in antigen test group). Reported severity of symptoms was lower in the clinical score group (-0.33, 95% confidence interval -0.64 to -0.02; P=0.04), equivalent to one in three rating sore throat a slight versus moderate problem, with a similar reduction for the antigen test group (-0.30, -0.61 to -0.00; P=0.05). Symptoms rated moderately bad or worse resolved significantly faster in the clinical score group (hazard ratio 1.30, 95% confidence interval 1.03 to 1.63) but not the antigen test group (1.11, 0.88 to 1.40). In the delayed antibiotics group, 75/164 (46%) used antibiotics. Use of antibiotics in the clinical score group (60/161) was 29% lower (adjusted risk ratio 0.71, 95% confidence interval 0.50 to 0.95; P=0.02) and in the antigen test group (58/164) was 27% lower (0.73, 0.52 to 0.98; P=0.03). There were no significant differences in complications or reconsultations.

conclusionTargeted use of antibiotics for acute sore throat with a clinical score improves reported symptoms and reduces antibiotic use. Antigen tests used according to a clinical score provide similar benefits but with no clear advantages over a clinical score alone.

trial registrationISRCTN32027234.

Indexed as

Anti-Bacterial AgentsAntigens, BacterialDrug Administration ScheduleFemaleHumansImmunologic TestsMalePharyngitisSensitivity and SpecificityStreptococcal InfectionsStreptococcus pyogenesSurveys and QuestionnairesUnited KingdomAnti-Bacterial AgentsAntigens, Bacterial

Identifiers

PMID24114306
PMCPMC3805475
OpenAlexW2044331325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.